Comparison of Keppra and Clonidine in the Treatment of Tics

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

June 30, 2009

Conditions
Tic DisordersTourette Syndrome
Interventions
DRUG

Levetiracetam

The initial dose of levetiracetam was 10 mg/kg/day, divided twice daily (rounded to the closest unit of 250 mg). The dose was increased weekly by 5-10 mg/kg/day, to a maximum dose of 50 mg/kg/day (or 2,500 mg/day), if deemed necessary for tic suppression. In any individual, dose escalation may have proceeded more slowly, or the dose may have been reduced as necessary. No changes in dosage occurred during the final week of either treatment phase.

DRUG

Clonidine

The initial dose of clonidine was 0.05 mg, twice daily. If needed for tic suppression, the dose was increased weekly by 0.05-0.1 mg, with a maximum dose of 0.4 mg per day. In any individual, dose escalation may have proceeded more slowly, or the dose may have been reduced as necessary. No changes in dosage occurred during the final week of either treatment phase.

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Harvey S. Singer

OTHER